IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorHanoi Medical University

About this trial

The goal of this clinical trial is to compare two ovarian stimulation protocols used in in vitro fertilization (IVF): the fixed Progestin-Primed Ovarian Stimulation (PPOS) protocol and the GnRH Antagonist protocol. The study will evaluate IVF outcomes and embryo development patterns using time-lapse embryo monitoring technology. The main questions the study aims to answer are:

* Does the fixed - PPOS protocol achieve similar numbers of mature eggs, good-quality embryos, and clinical outcomes compared to the GnRH Antagonist protocol? * Are there differences in embryo development patterns (morphokinetics) between the two protocols when monitored by time-lapse imaging? * How does embryo quality (KIDScore) compare between the two protocols?

Study Design:

Researchers will randomly assign 148 women undergoing IVF to two groups:

* PPOS group (n=74): Will receive FSH injections (oral Duphaston 20mg daily) starting from day 2-3 of the menstrual cycle * GnRH Antagonist group (n=74): Will receive FSH injections (Orgalutran 0.25mg injections) when follicles reach ≥14mm

Participants will:

* Undergo controlled ovarian stimulation with their assigned protocol for approximately 10-12 days * Have regular ultrasound monitoring and blood tests to track follicle development * Undergo egg retrieval procedure when follicles are mature * Have all embryos cultured in the EmbryoScope time-lapse incubator with continuous monitoring * Have embryos frozen on Day 5/6 for future transfer

Study Location:

Department of Assisted Reproduction and Andrology, Hanoi Obstetrics and Gynecology Hospital

Study Duration: January 2026 - June 2028

Eligibility criteria

Qualifiers

Women aged 20-45 years

Indicated for in vitro fertilization (IVF) treatment

Planned freeze-all embryo strategy

Voluntary participation in research.

Disqualifiers

Systemic diseases

Use of hormonal medications within 3 months prior to enrollment

Oocyte donation cycles

Unwilling or unable to participate in research

Trial design

Treatments tested in this trial

  • Progestin-Primed Ovarian Stimulation
  • Antagonist protocol for IVF

Treatment groups

148 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hanoi Medical University

Lead sponsor

Hanoi Obstetrics and Gynecology Hospital

Collaborator